Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:EZZ
ASX:EZZPersonal Products

ASX Penny Stocks To Watch In August 2025

The ASX200 has traded fairly flat today, with the telecommunications sector leading gains while energy lagged behind. Amidst this mixed performance, investors are increasingly looking towards penny stocks as an area of interest. Though often seen as a relic from past market eras, penny stocks offer unique opportunities for growth at lower price points, especially when they exhibit strong financials and solid fundamentals.
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines (LUNR) Sees US$38 Million Net Loss In Recent Quarterly Performance

Intuitive Machines (LUNR) reported a notable quarterly performance on August 7, 2025, with sales increasing to $50.31 million, but a net loss of $38.59 million contrasted sharply with last year's profit. Despite securing a $9.8 million government contract and pursuing strategic mergers and acquisitions, the company's share price dropped 10.49% last week. This decline occurred as major indexes like the Dow and S&P 500 hovered near record highs, closing with slight gains over the same period...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Reports Net Loss of US$143M for Q2 2025

USA Rare Earth (USAR) recently reported a net loss of USD 143 million for Q2 2025, signaling financial hurdles. However, a notable 82% rise in its share price last quarter coincides with strategic partnerships, including an MOU with Enduro Pipeline Services and a joint development agreement with ePropelled to produce neo magnets, reinforcing growth prospects despite market volatility. Concurrently, broader market trends saw marginal dips in major indices as stocks hovered near record highs...
NasdaqGM:GAMB
NasdaqGM:GAMBMedia

Gambling.com Group (GAMB) Expands Equity Buyback Plan By US$10 Million

Last week, Gambling.com Group (GAMB) reported its Q2 2025 earnings, which showed promising sales growth from $30.54 million to $39.59 million year-over-year, but also revealed a net loss of $13.42 million against a previous net income of $6.93 million. Additionally, the company expanded its equity buyback plan by $10 million. Despite these moves, GAMB's stock fell by 14%. This decline contrasts with broader market trends where major indices hovered near record highs and posted gains for a...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

Prairie Operating (PROP) Sees US$35.7 Million Net Income Turnaround in Q2 2025 Earnings

Prairie Operating (PROP) recently announced its Q2 2025 earnings, reporting a significant turnaround with a net income of $35.7 million, compared to a net loss in the same quarter last year. Despite this positive financial performance and updated corporate guidance projecting robust production and net income for 2025, the company's stock saw a 24% decline over the past week. This move counteracted broader market trends, where major indexes hovered near record highs after two consecutive weeks...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

United States Antimony (UAMY) Revenue Soars To US$11 Million In Strong Quarter

United States Antimony (UAMY) experienced a notable quarter with a 63% increase in share price, benefiting from strong corporate developments. The company reaffirmed its revenue guidance for the year, projecting an optimistic outlook with revenues expected between $40 million and $50 million. Despite a slight drop in quarterly net income to $0.18 million, sales grew significantly to $10.53 million from $3.66 million year-over-year. Moreover, the company's business expansions, particularly in...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Gains As FDA Approves BRINSUPRI For New Market

Insmed (INSM) saw a significant price move of 87% over the past quarter, driven by pivotal product developments and regulatory milestones. The FDA's approval of BRINSUPRI as the first oral treatment for non-cystic fibrosis bronchiectasis was a key highlight, potentially opening up a substantial market opportunity. Meanwhile, the designation of Maxor Specialty Pharmacy as a limited distribution provider further strengthened the product's market presence. Despite reporting a net loss for Q2...
NYSE:ESTC
NYSE:ESTCSoftware

August 2025's Intriguing Stocks That May Be Priced Below Estimated Value

As the U.S. stock market hovers near record highs following two consecutive weeks of gains, investors are closely monitoring interest rate expectations and retail earnings reports for further insights. In such a climate, identifying stocks that may be priced below their estimated value can offer potential opportunities for those looking to navigate these nuanced economic conditions effectively.
NasdaqGS:VIR
NasdaqGS:VIRBiotechs

Black Diamond Therapeutics And 2 Promising Penny Stocks For Savvy Investors

As the major U.S. stock indices hover near record highs following two consecutive weeks of gains, investors are closely monitoring economic indicators and corporate earnings for signs of market direction. In this context, penny stocks—often representing smaller or emerging companies—can present unique opportunities for those seeking value and growth potential outside the mainstream market. Though traditionally seen as speculative, these stocks may offer promising prospects when backed by...